GIUSTINA, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 23.171
AS - Asia 9.604
EU - Europa 7.631
SA - Sud America 1.686
Continente sconosciuto - Info sul continente non disponibili 304
AF - Africa 201
OC - Oceania 24
Totale 42.621
Nazione #
US - Stati Uniti d'America 22.888
CN - Cina 3.524
SG - Singapore 3.143
UA - Ucraina 2.590
BR - Brasile 1.390
HK - Hong Kong 1.200
DE - Germania 1.061
PL - Polonia 781
FR - Francia 717
FI - Finlandia 622
VN - Vietnam 534
GB - Regno Unito 453
IT - Italia 401
TR - Turchia 375
IE - Irlanda 372
RU - Federazione Russa 363
IN - India 292
CA - Canada 152
BD - Bangladesh 149
AR - Argentina 91
ZA - Sudafrica 68
MX - Messico 66
IQ - Iraq 60
SE - Svezia 54
EC - Ecuador 50
ID - Indonesia 42
JP - Giappone 42
ES - Italia 39
NG - Nigeria 37
NL - Olanda 35
PY - Paraguay 35
SA - Arabia Saudita 34
CO - Colombia 33
PK - Pakistan 33
BE - Belgio 28
MA - Marocco 28
CZ - Repubblica Ceca 27
CL - Cile 26
IR - Iran 25
VE - Venezuela 25
PE - Perù 23
UZ - Uzbekistan 23
AU - Australia 22
JM - Giamaica 22
AE - Emirati Arabi Uniti 20
EU - Europa 20
AT - Austria 17
NP - Nepal 14
KE - Kenya 13
JO - Giordania 12
AZ - Azerbaigian 11
PT - Portogallo 10
CR - Costa Rica 9
EG - Egitto 9
IL - Israele 9
KZ - Kazakistan 9
LT - Lituania 9
DZ - Algeria 8
ET - Etiopia 8
RO - Romania 8
TN - Tunisia 8
HN - Honduras 7
KR - Corea 7
UY - Uruguay 7
MY - Malesia 6
OM - Oman 6
BO - Bolivia 5
CH - Svizzera 5
MU - Mauritius 5
PH - Filippine 5
SV - El Salvador 5
AL - Albania 4
BB - Barbados 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
EE - Estonia 4
LV - Lettonia 4
PA - Panama 4
RS - Serbia 4
TH - Thailandia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
CM - Camerun 3
DK - Danimarca 3
GE - Georgia 3
GT - Guatemala 3
LB - Libano 3
NI - Nicaragua 3
NO - Norvegia 3
SN - Senegal 3
AM - Armenia 2
BS - Bahamas 2
BW - Botswana 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
ML - Mali 2
MN - Mongolia 2
Totale 42.314
Città #
Fairfield 3.211
Woodbridge 2.448
Ashburn 2.009
Houston 1.756
Jacksonville 1.741
Singapore 1.669
Cambridge 1.303
Ann Arbor 1.282
Seattle 1.224
Hong Kong 1.190
Wilmington 1.112
Warsaw 771
Princeton 692
Nanjing 637
Beijing 635
The Dalles 626
San Jose 587
Chandler 515
Dublin 370
New York 330
Lauterbourg 303
Columbus 298
Istanbul 298
Helsinki 266
Nanchang 256
Los Angeles 253
Moscow 201
Des Moines 188
Ho Chi Minh City 184
Shenyang 167
Buffalo 159
Changsha 142
San Diego 132
Hebei 127
São Paulo 119
Hanoi 116
Tianjin 116
Jiaxing 112
Milan 107
Redondo Beach 104
Council Bluffs 101
Munich 80
Chicago 78
Shanghai 75
Kunming 72
Dallas 68
Jinan 68
San Francisco 67
Santa Clara 63
Brescia 62
Orem 59
Hangzhou 50
Verona 50
Dearborn 49
Lancaster 44
London 44
Rio de Janeiro 42
Tokyo 42
Toronto 41
Abuja 37
Lanzhou 37
San Mateo 37
Montreal 36
Johannesburg 35
Kocaeli 35
Brooklyn 34
Chennai 34
Guangzhou 33
Haikou 33
Phoenix 33
Atlanta 32
Zhengzhou 32
Mexico City 30
Turku 30
Belo Horizonte 29
Manchester 29
Ningbo 29
Boardman 28
Dong Ket 28
Leawood 28
Dhaka 27
Denver 26
Brussels 24
Poplar 24
Augusta 23
Curitiba 22
Porto Alegre 22
Taizhou 22
Brasília 21
Quito 21
Brno 20
Stockholm 20
Charlotte 19
Da Nang 19
Mumbai 19
Tashkent 19
Ankara 18
Ardabil 18
Changchun 18
Baghdad 17
Totale 30.009
Nome #
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 362
Elevated intraocular pressure in patients with acromegaly 342
Ghrelin regulates proliferation and differentiation of osteoblastic cells 275
Guidelines for acromegaly management. 231
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. 229
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 205
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 197
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 196
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 193
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 193
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 192
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 192
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 191
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 185
Growth hormone deficiency in treated acromegaly 181
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 179
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 174
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 174
Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. 169
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 167
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. 166
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 166
Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells 165
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals 160
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 159
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. 157
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 157
Diagnosis and treatment of acromegaly complications. 155
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 155
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. 155
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. 155
The management of the patient with acromegaly and headache: a still open clinical challenge. 153
A consensus on criteria for cure of acromegaly. 153
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. 152
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 151
Guidelines for acromegaly management: an update. 149
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 149
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. 149
A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients. 149
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 149
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 147
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. 147
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study. 147
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 147
Growth hormone deficiency in the adult. 145
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 145
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cell 145
High prevalence of radiological vertebral fractures in HIV-infected males 145
Cardiovascular risk in aging and obesity: is there a role for GH. 145
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. 144
Acromegalic patients show the presence of hypertrophic remodelling of subcutaneous small resistance arteries 144
Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. 144
Ambulatory blood pressure monitoring (ABPM) in normotensive patients with acromegaly effect of 24-h continous infusion of octreotide. 144
Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? 143
Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly. 143
Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells 143
Pituitary testing: a reappraisal. 143
Long-term Picotamide, a dual thromboxane inhibitor, decreases both the urinary excretion of thromboxane B2 (TXB2) and albumin in patients with type 2 diabetes. 142
A consensus on criteria for cure acromegaly 142
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 142
Expert consensus document:A consensus on the medical treatment of acromegaly 142
Prevalence of vertebral fractures in men with acromegaly 141
Role of food intake in the modulation of hexarelin-induced growth hormone release in normal human subjects. 141
Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. 141
New understanding and treatments for osteoporosis. 140
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 139
Octreotide for acromegaly treatment: a reappraisal. 139
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 138
[Effects of acute administration of nifedipine on exercise-induced microalbuminuria in normotensive patients with type 1 diabetes]. 138
CORTISOL AND THE MUSCLE-BONE AXIS:RESPONSE TO COMMENTS BY MOLFINO ET AL. 138
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 138
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 138
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 137
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis. 137
Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. 137
Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart. 136
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. 136
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 136
New oral anticoagulants and pituitary apoplexy 136
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 136
Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH-an update. 136
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. 135
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients. 135
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 134
Growth hormone in glucocorticoid-induced osteoporosis. 134
Hypertrophic remodeling of subcutaneous small resistance arteries in acromegalic patients 134
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 134
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 133
Glucocorticoids and the regulation of growth hormone secretion. 133
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 133
TREATMENT OF HYPOTHYROIDISM:ALL THAT GLITTERS IS GOLD? 133
Leptin stimulates growth hormone secretion via a direct pituitary effect combined with a decreased somatostatin tone in a median eminence-pituitary perifusion study. 132
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 132
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 132
Development of isolated ACTH deficiency in a man with type I diabetes mellitus. 132
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 132
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. 131
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. 131
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. 131
Current guidelines for adult GH replacement. 130
Totale 15.639
Categoria #
all - tutte 199.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 199.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.290 0 492 35 109 12 147 98 159 117 358 209 554
2022/20231.774 387 48 10 94 150 568 2 143 234 15 58 65
2023/20241.984 107 38 92 158 91 287 112 42 670 24 14 349
2024/20254.411 15 14 18 605 577 376 316 97 531 262 1.003 597
2025/20268.971 991 1.283 686 1.460 874 534 1.405 302 458 623 254 101
2026/2027665 496 169 0 0 0 0 0 0 0 0 0 0
Totale 42.621